Literature DB >> 32197542

Erythrocytes as Carriers: From Drug Delivery to Biosensors.

Larisa Koleva1,2, Elizaveta Bovt1,2, Fazoil Ataullakhanov1,2,3, Elena Sinauridze1,2.   

Abstract

Drug delivery using natural biological carriers, especially erythrocytes, is a rapidly developing field. Such erythrocytes can act as carriers that prolong the drug's action due to its gradual release from the carrier; as bioreactors with encapsulated enzymes performing the necessary reactions, while remaining inaccessible to the immune system and plasma proteases; or as a tool for targeted drug delivery to target organs, primarily to cells of the reticuloendothelial system, liver and spleen. To date, erythrocytes have been studied as carriers for a wide range of drugs, such as enzymes, antibiotics, anti-inflammatory, antiviral drugs, etc., and for diagnostic purposes (e.g. magnetic resonance imaging). The review focuses only on drugs loaded inside erythrocytes, defines the main lines of research for erythrocytes with bioactive substances, as well as the advantages and limitations of their application. Particular attention is paid to in vivo studies, opening-up the potential for the clinical use of drugs encapsulated into erythrocytes.

Entities:  

Keywords:  carrier erythrocyte; diagnostics; drug delivery; erythrocyte; erythrocyte-bioreactor; targeted drug delivery; therapy

Year:  2020        PMID: 32197542     DOI: 10.3390/pharmaceutics12030276

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  14 in total

1.  Antibody-engineered red blood cell interface for high-performance capture and release of circulating tumor cells.

Authors:  Haicong Shen; Rui Su; Jiao Peng; Lin Zhu; Kunyue Deng; Qi Niu; Yanling Song; Liu Yang; Lingling Wu; Zhi Zhu; Chaoyong Yang
Journal:  Bioact Mater       Date:  2021-10-05

Review 2.  Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.

Authors:  Patrick M Glassman; Elizabeth D Hood; Laura T Ferguson; Zongmin Zhao; Don L Siegel; Samir Mitragotri; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2021-09-29       Impact factor: 15.470

3.  Light-Triggered Drug Release from Red Blood Cells Suppresses Arthritic Inflammation.

Authors:  Emilia M Zywot; Natalia Orlova; Song Ding; Rishi R Rampersad; Emily M Rabjohns; Victoria A Wickenheisser; Qunzhao Wang; Joshua G Welfare; Lauren Haar; Amanda M Eudy; Teresa K Tarrant; David S Lawrence
Journal:  Adv Ther (Weinh)       Date:  2021-10-13

4.  Theoretical Analysis of the Built-in Metabolic Pathway Effect on the Metabolism of Erythrocyte-Bioreactors That Neutralize Ammonium.

Authors:  Evgeniy Protasov; Larisa Koleva; Elizaveta Bovt; Fazoil I Ataullakhanov; Elena Sinauridze
Journal:  Metabolites       Date:  2021-01-06

Review 5.  Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy.

Authors:  Maaike Van Trimpont; Evelien Peeters; Yanti De Visser; Amanda M Schalk; Veerle Mondelaers; Barbara De Moerloose; Arnon Lavie; Tim Lammens; Steven Goossens; Pieter Van Vlierberghe
Journal:  Cancers (Basel)       Date:  2022-02-11       Impact factor: 6.639

Review 6.  Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice.

Authors:  Stefano Bruscoli; Marta Febo; Carlo Riccardi; Graziella Migliorati
Journal:  Front Immunol       Date:  2021-06-03       Impact factor: 7.561

Review 7.  Chronicles of Nanoerythrosomes: An Erythrocyte-Based Biomimetic Smart Drug Delivery System as a Therapeutic and Diagnostic Tool in Cancer Therapy.

Authors:  Shamama Javed; Sultan Alshehri; Ambreen Shoaib; Waquar Ahsan; Muhammad Hadi Sultan; Saad Saeed Alqahtani; Mohsin Kazi; Faiyaz Shakeel
Journal:  Pharmaceutics       Date:  2021-03-10       Impact factor: 6.321

Review 8.  Phototheranostics Using Erythrocyte-Based Particles.

Authors:  Taylor Hanley; Raviraj Vankayala; Chi-Hua Lee; Jack C Tang; Joshua M Burns; Bahman Anvari
Journal:  Biomolecules       Date:  2021-05-13

Review 9.  Nucleic Acid Delivery with Red-Blood-Cell-Based Carriers.

Authors:  Giulia Della Pelle; Nina Kostevšek
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

10.  The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics.

Authors:  Qiuxia Yu; Minhua Li; Hanbin Chen; Lieqiang Xu; Juanjuan Cheng; Guoshu Lin; Yuhong Liu; Ziren Su; Xiaobo Yang; Yucui Li; Jiannan Chen; Jianhui Xie
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.